Hepadnavirus Infections

Hepadnavirus infections are illnesses caused by viruses called hepadnaviruses. These viruses are related to the hepatitis viruses, which can affect your liver. Infections can range from mild to severe, and sometimes lead to long-term liver problems like cirrhosis or liver cancer. Doctors can diagnose these infections through blood tests and sometimes imaging scans.

Condition

What people with Hepadnavirus Infections report

Every report comes from a Lived member, sent anonymously.

Have you tried Tenofovir for Hepadnavirus Infections?

NameHow it went

About Hepadnavirus Infections

What It Is

Hepadnavirus infections are infections caused by viruses in the Hepadnaviridae family, a group of small DNA viruses that live inside liver cells. Different members of the family infect ducks, woodchucks, bats and other animals, but only one causes disease in people: the hepatitis B virus (HBV). For a person, a hepadnavirus infection means hepatitis B. Hepatitis B inflames the liver and can damage it. A new, or acute, infection often causes no symptoms at all. When it does, people may notice tiredness, nausea, loss of appetite, belly pain, dark urine, pale stools or yellowing of the skin and eyes (jaundice), usually beginning weeks to a few months after exposure. Most adults clear the virus on their own. When it is still present after six months, the infection is called chronic. Age at infection largely decides which path the virus takes. About 90% of babies infected in their first year develop chronic hepatitis B, compared with about 5% of adults. Chronic infection can stay silent for decades while it slowly scars the liver, which is why it matters: over time it can lead to cirrhosis (severe, permanent scarring), liver failure and liver cancer. The World Health Organization estimates that about 240 million people live with chronic hepatitis B worldwide.

Causes & Risk Factors

HBV spreads through contact with the blood, semen or other body fluids of someone who carries the virus. Worldwide, it passes most often from mother to baby around the time of birth, or between young children. In the United States, adults most often get it through sex or through shared needles and other drug-injection equipment. Shared razors, toothbrushes or nail clippers, unsterile tattoo or piercing tools and needlestick injuries at work can also spread it. The chance of having hepatitis B is higher for people born in parts of Asia, Africa, the Middle East, Eastern Europe or South America where the infection is common, and for people born in the United States who were not vaccinated as infants and whose parents came from those regions. Most Americans living with chronic hepatitis B were born outside the country. Risk is also higher for people who live with or have sex with someone who has hepatitis B, people with several sex partners or a past sexually transmitted infection, men who have sex with men, people who inject drugs, people with HIV or hepatitis C, people on dialysis and people who have been incarcerated. The hepatitis B vaccine prevents infection very effectively, and having it removes most of this risk. In someone who already has chronic hepatitis B, other factors can speed up liver damage: alcohol, fatty liver disease, and infection with HIV, hepatitis C or hepatitis D. Hepatitis D is a separate virus that can only infect people who already carry hepatitis B, and it tends to make liver disease worse.

How It's Diagnosed

Hepatitis B is diagnosed with blood tests, because symptoms alone cannot tell it apart from other kinds of hepatitis. The US Centers for Disease Control and Prevention (CDC) recommends that every adult be screened at least once, and pregnant people during every pregnancy, using three tests together. Hepatitis B surface antigen (HBsAg) is a piece of the virus; a positive result means the virus is in the body now. Surface antibody (anti-HBs) shows protection, either from the vaccine or from recovering from an earlier infection. Core antibody (anti-HBc) shows that a person has been infected at some point; the vaccine does not cause it. Read together, the results sort people into groups. A positive HBsAg means a current infection, and if it stays positive for six months or more, the infection is chronic. A negative HBsAg with positive surface and core antibodies means a past infection that has resolved, although the virus can still wake up later if the immune system is suppressed. Surface antibody alone usually reflects vaccination. If all three are negative, the person has never been infected and can be vaccinated. For someone with chronic hepatitis B, further tests show how active the virus is and how the liver is coping. HBV DNA (the viral load) measures how much virus is in the blood. ALT (alanine aminotransferase), a liver enzyme, rises when liver cells are being injured; for hepatitis B care, liver specialists treat about 35 units per liter in men and 25 in women as the upper limit of normal. Because the infection moves through phases, these numbers are usually repeated over time rather than judged once. A liver stiffness scan (elastography) or ultrasound estimates scarring, and a liver biopsy is needed only occasionally. People with hepatitis B are also tested for hepatitis C and, when at risk, for HIV and hepatitis D.

Treatment Options

There is no specific antiviral treatment for most acute hepatitis B. Care focuses on rest, fluids and good nutrition, avoiding alcohol and anything else that strains the liver, and blood tests to confirm that the virus clears. A small number of people develop severe acute hepatitis that needs hospital care, and rarely a liver transplant. Not everyone with chronic hepatitis B needs medicine. Treatment is recommended when tests show ongoing liver inflammation together with significant viral levels, and for everyone with cirrhosis. The main treatments are once-daily antiviral pills: tenofovir, sold as Vemlidy (tenofovir alafenamide) and Viread (tenofovir disoproxil fumarate), and entecavir. They stop the virus from copying itself, which lowers the viral load, calms liver inflammation, slows scarring, reduces the chance of liver cancer and improves long-term survival. Side effects are uncommon, and the choice between them often depends on kidney and bone health. These medicines control the virus but do not cure it, so most people take them for many years and often for life. Stopping a hepatitis B antiviral can trigger a sudden, sometimes severe flare of liver inflammation. Treatment should be stopped only with the prescriber's agreement and with close blood-test monitoring for months afterward. Peginterferon alfa, a weekly injection that boosts the immune response, is a less common option given for a set period, usually about a year. It is harder to tolerate than the pills and is not suitable for people with advanced cirrhosis, autoimmune disease or poorly controlled psychiatric illness. When chronic hepatitis B leads to liver failure or certain liver cancers, a liver transplant may be possible, with medicines afterward to keep the virus from infecting the new liver. During pregnancy, a person with a high viral load may be offered tenofovir in the later months to lower the chance of passing the virus to the baby. Every baby born to a mother with hepatitis B should receive hepatitis B immune globulin (HBIG, ready-made antibodies) and the first dose of the hepatitis B vaccine right after birth. With that protection, breastfeeding is considered safe.

What to Expect

Most adults with acute hepatitis B recover over several weeks to a few months and are then protected against catching it again. A trace of the virus can remain in the liver for life, though, which is why a past infection still matters if strong immune-suppressing treatment is ever needed. Chronic hepatitis B is usually a long-term condition that changes over time. Many people feel well for years and may never need medicine, while others move into a more active phase in which treatment becomes worthwhile. Either way, regular blood tests with a clinician experienced in liver disease are the core of care, because the virus and liver numbers can shift without any symptoms. People at higher risk of liver cancer, including everyone with cirrhosis, anyone with a close relative who had liver cancer, people with hepatitis D, Asian and Black men over 40 and Asian women over 50, are advised to have a liver ultrasound every six months. Antiviral treatment lowers the risk of liver cancer but does not remove it, so this monitoring continues even when the virus is well controlled. Day to day, protecting the liver means avoiding alcohol, keeping a healthy weight (because fatty liver adds to the damage) and checking with a clinician before starting new medicines or supplements. Protecting others means asking sex partners and people in the household to get tested and vaccinated, not sharing razors, toothbrushes or nail clippers, covering cuts, not donating blood, organs or semen, and telling health care providers about the infection. Research into medicines that could cure the infection is ongoing, but none is available yet.

When to Seek Help

Ask about a hepatitis B blood test if you have never been screened, since all adults are advised to be tested at least once, and ask about the vaccine if you are not protected. If you are diagnosed, see a clinician who manages liver disease even if you feel well. Contact a clinician right away after a possible exposure if you are not vaccinated, such as a needlestick, a sexual assault or unprotected sex with someone who has hepatitis B. A vaccine dose, sometimes with HBIG, works best when given within 24 hours. Before starting chemotherapy, rituximab or other strong immune-suppressing treatment, tell the care team about current or past hepatitis B, because the virus can reactivate and preventive antiviral medicine is often started first. Call your prescriber promptly if you have stopped or run out of your antiviral. Seek urgent medical care the same day for new or deepening yellowing of the skin or eyes, confusion or unusual sleepiness, or a belly that is quickly swelling with fluid, because these can be signs that the liver is failing.

Questions to Ask Your Doctor

  1. 1.Based on my blood tests, is my hepatitis B active, and do I need treatment now or monitoring?
  2. 2.How much scarring does my liver have, and how will we check it over time?
  3. 3.Do I need regular ultrasounds to check for liver cancer, and how often?
  4. 4.Should I be tested for hepatitis D, and do my partner and family members need testing or the vaccine?
  5. 5.If I need cancer treatment or another immune-suppressing medicine in the future, what should happen first?

Last reviewed • Oct 2026

Educational content, not medical advice.